文献
J-GLOBAL ID:201702244633372256
整理番号:17A1830102
初回ゲフィチニブまたはエルロチニブ治療を受けている進行非小細胞肺癌患者における予後不良を予測する上昇好中球へのリンパ球比【Powered by NICT】
Elevated neutrophil-to-lymphocyte ratio predicts poor outcome in patients with advanced non-small-cell lung cancer receiving first-line gefitinib or erlotinib treatment
著者 (6件):
Lin Gui-Nan
(Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People’s Hospital, Zhongshan, China)
,
Peng Jie-Wen
(Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People’s Hospital, Zhongshan, China)
,
Liu Pan-Pan
(Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China)
,
Liu Dong-Ying
(Department of Clinical Oncology, Jiangmen Hospital of Sun Yat-sen University, Jiangmen Central Hospital, Jiangmen, China)
,
Xiao Jian-jun
(Department of Medical Oncology, Zhongshan Hospital of Sun Yat-sen University, Zhongshan City People’s Hospital, Zhongshan, China)
,
Chen Xiao-Qin
(Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China)
資料名:
Asia-Pacific Journal of Clinical Oncology
(Asia-Pacific Journal of Clinical Oncology)
巻:
13
号:
5
ページ:
e189-e194
発行年:
2017年
JST資料番号:
W2498A
ISSN:
1743-7555
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)